Individual participant data meta-analyses compared with meta-analyses based on aggregate data

[1]  Catrin Tudur Smith,et al.  Combining individual patient data and aggregate data in mixed treatment comparison meta‐analysis: Individual patient data may be beneficial if only for a subset of trials , 2013, Statistics in medicine.

[2]  J. Jansen,et al.  Efficacy of once-daily indacaterol 75 μg relative to alternative bronchodilators in COPD: A study level and a patient level network meta-analysis , 2012, BMC Pulmonary Medicine.

[3]  J. Crawford,et al.  Benefits and risks of using erythropoiesis-stimulating agents (ESAs) in lung cancer patients: study-level and patient-level meta-analyses. , 2012, Lung cancer.

[4]  J. Manson,et al.  Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials. , 2012, The Journal of clinical endocrinology and metabolism.

[5]  A. Sutton,et al.  Assessment of publication bias, selection bias, and unavailable data in meta-analyses using individual participant data: a database survey , 2012, BMJ : British Medical Journal.

[6]  M. Sampson,et al.  Checking reference lists to find additional studies for systematic reviews. , 2011, The Cochrane database of systematic reviews.

[7]  P. Rothwell,et al.  Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials , 2011, The Lancet.

[8]  Neil Marlow,et al.  Elective high-frequency oscillatory versus conventional ventilation in preterm infants: a systematic review and meta-analysis of individual patients' data , 2010, The Lancet.

[9]  Charles K. Cooper,et al.  Meta-analysis of a possible signal of increased mortality associated with cefepime use. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  Harris Cooper,et al.  The relative benefits of meta-analysis conducted with individual participant data versus aggregated data. , 2009, Psychological methods.

[11]  Anne Whitehead,et al.  Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials , 2009, Clinical trials.

[12]  J. Gladman,et al.  Hospital at home early discharge , 2009 .

[13]  J. Camm,et al.  Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with implantable cardioverter defibrillators. , 2008, European heart journal.

[14]  A. Hoes,et al.  Empirical comparison of subgroup effects in conventional and individual patient data meta-analyses , 2008, International Journal of Technology Assessment in Health Care.

[15]  J. Trachtenberg,et al.  Maximal androgen blockade for the treatment of metastatic prostate cancer—a systematic review , 2006, Current oncology.

[16]  Paula R Williamson,et al.  An overview of methods and empirical comparison of aggregate data and individual patient data results for investigating heterogeneity in meta-analysis of time-to-event outcomes. , 2005, Journal of Evaluation In Clinical Practice.

[17]  P. Sandercock,et al.  Alteplase and ischaemic stroke: have new reviews of old data helped? , 2005, The Lancet Neurology.

[18]  Stefan Michiels,et al.  Meta-analysis when only the median survival times are known: A comparison with individual patient data results , 2005, International Journal of Technology Assessment in Health Care.

[19]  Junichi Sakamoto,et al.  Individual patient-level and study-level meta-analysis for investigating modifiers of treatment effect. , 2004, Japanese journal of clinical oncology.

[20]  Paul Landais,et al.  Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors. , 2004, Journal of clinical epidemiology.

[21]  Harold I Feldman,et al.  Individual patient‐ versus group‐level data meta‐regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head , 2002, Statistics in medicine.

[22]  R M Turner,et al.  Multilevel models for meta-analysis, and their application to absolute risk differences , 2001, Statistical methods in medical research.

[23]  L. Stewart,et al.  Feasibility and reliability of using hazard ratios in meta-analyses of published time-to-event data , 2001 .

[24]  J. Pignon,et al.  Individual patient-versus literature-based meta-analysis of survival data: time to event and event rate at a particular time can make a difference, an example based on head and neck cancer. , 2001, Controlled clinical trials.

[25]  H Goldstein,et al.  A multilevel model framework for meta-analysis of clinical trials with binary outcomes. , 2000, Statistics in medicine.

[26]  J L Hutton,et al.  Individual patient data meta-analysis of randomized anti-epileptic drug monotherapy trials. , 2000, Journal of evaluation in clinical practice.

[27]  C. Davis,et al.  Palliative chemotherapy for advanced or metastatic colorectal cancer. Colorectal Meta-analysis Collaboration. , 2000, The Cochrane database of systematic reviews.

[28]  T. Mathew,et al.  On the Equivalence of Meta‐Analysis Using Literature and Using Individual Patient Data , 1999, Biometrics.

[29]  J. Ioannidis,et al.  Recursive cumulative meta-analysis: a diagnostic for the evolution of total randomized evidence from group and individual patient data. , 1999, Journal of clinical epidemiology.

[30]  M. Clarke,et al.  Systematic reviews using individual patient data: a map for the minefields? , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[31]  J. Berlin,et al.  The Effect of Antilymphocyte Induction Therapy on Renal Allograft Survival , 1998, Annals of Internal Medicine.

[32]  V Torri,et al.  Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials , 1998, BMJ.

[33]  I Olkin,et al.  Comparison of meta-analysis versus analysis of variance of individual patient data. , 1998, Biometrics.

[34]  L. Santoro,et al.  P118 Prospective meta-analysis using individual patient data vs meta-analysis of published reports: The case of ace-inhibitors in myocardial infarction , 1997 .

[35]  I Olkin,et al.  Comparison of effect estimates from a meta-analysis of summary data from published studies and from a meta-analysis using individual patient data for ovarian cancer studies. , 1997, American journal of epidemiology.

[36]  T. Chevalier.  Chemotherapy for Advanced NSCLC , 1996 .

[37]  L. Beckett,et al.  Validation of a meta-analysis: the effects of fish oil in rheumatoid arthritis. , 1995, Journal of clinical epidemiology.

[38]  L. Stewart,et al.  Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group. , 1995, Statistics in medicine.

[39]  L F Burmeister,et al.  A comparison of meta-analytic results using literature vs individual patient data. Paternal cell immunization for recurrent miscarriage. , 1995, JAMA.

[40]  I. Chalmers.  The Cochrane Collaboration: Preparing, Maintaining, and Disseminating Systematic Reviews of the Effects of Health Care , 1993, Annals of the New York Academy of Sciences.

[41]  M. Parmar,et al.  Meta-analysis of the literature or of individual patient data: is there a difference? , 1993, The Lancet.

[42]  R. Arriagada,et al.  Role of thoracic radiotherapy in limited-stage small-cell lung cancer: quantitative review based on the literature versus meta-analysis based on individual data. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  J. Bohlius,et al.  Ten years of meta-analyses on erythropoiesis-stimulating agents in cancer patients. , 2011, Cancer treatment and research.

[44]  P C Lambert,et al.  A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis. , 2002, Journal of clinical epidemiology.

[45]  Paula R. Williamson,et al.  The value of the aggregate data approach in meta‐analysis with time‐to‐event outcomes , 2001 .

[46]  R. Salamon,et al.  [Effect of dapsone on survival in HIV infected patients: a meta- analysis of finished trials]. , 2000, Revue d'epidemiologie et de sante publique.

[47]  Mike Clarke,et al.  Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.